Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Maria Angela Massaro is active.

Publication


Featured researches published by Maria Angela Massaro.


Archives of Otolaryngology-head & Neck Surgery | 2009

Laser Surgery for Early Glottic Cancer Impact of Margin Status on Local Control and Organ Preservation

Mohssen Ansarin; Luigi Santoro; Augusto Cattaneo; Maria Angela Massaro; Luca Calabrese; Gioacchino Giugliano; Fausto Maffini; Angelo Ostuni; Fausto Chiesa

OBJECTIVE To assess the impact of margin status on disease-free survival, overall survival, and organ preservation in early glottic cancer treated by endoscopic laser surgery. DESIGN Prospective nonrandomized study. SETTING Tertiary referral center. PATIENTS A total of 274 patients with untreated (possibly biopsied) cTis, cT1a/b, cT2, cN0 glottic cancer; adequate exposure of the glottic region; no contraindications to general anesthesia; and the ability to give informed consent. INTERVENTIONS European Laryngological Society laser cordectomy. Patients with negative margins (>1 mm) were followed, patients with close margins (< or =1 mm) or 1 positive margin (tumor on margin) had another operation, and patients with more than 1 positive margin had postoperative radiotherapy. Median follow-up was 58 months. MAIN OUTCOME MEASURES Eight-year disease-free survival, 5-year overall survival, and organ preservation rate. RESULTS Margins were negative in 180 patients, close in 40, and positive in 54. A second laser resection was performed in 36 of 94 patients with close or positive margins. Radiotherapy was administered to 36 patients. Patients with close or positive margins who did not undergo further treatment had a greater recurrence risk (hazard ratio, 2.53; 95% confidence interval, 0.97-6.59, P = .06) than did those with negative margins, mainly owing to relapses in 5 of the 8 protocol breakers with positive margins not treated further. Eight-year relapse-free survival was 88.2%, 5-year overall survival was 90.9%, and the larynx was preserved in 97.1%. CONCLUSIONS Laser removal of early glottic cancer is oncologically adequate with margins greater than 1 mm from the tumor edge. Positive margins require further treatment; close margins may require further treatment depending on tumor characteristics.


International Journal of Medical Robotics and Computer Assisted Surgery | 2014

Transoral robotic surgery vs transoral laser microsurgery for resection of supraglottic cancer: a pilot surgery

Mohssen Ansarin; Stefano Zorzi; Maria Angela Massaro; Marta Tagliabue; Michele Proh; Gioacchino Giugliano; Luca Calabrese; Fausto Chiesa

Transoral laser microsurgery (TLM) is a mature approach to supraglottic cancer, while transoral robotic surgery (TORS) is emerging. The present study compared these approaches.


British Journal of Oral & Maxillofacial Surgery | 2013

Total glossectomy with preservation of the larynx: oncological and functional results.

Valeria Navach; Valeria Zurlo; Luca Calabrese; Maria Angela Massaro; Roberto Bruschini; Gioacchino Giugliano; Mohssen Ansarin; Fausto Chiesa

Our aim was to analyse the overall and disease-free survival (DFS), time to recovery of oral feeding, and morbidity, in a consecutive series of patients who had total glossectomy with preservation of the larynx for advanced cancer of the tongue at the European institute of Oncology (Milan). From June 2002 to April 2011, 37 patients who were treated for advanced cancer of the tongue had total glossectomy, bilateral neck dissection, and preservation of the larynx. Various flaps were used for reconstruction. Overall and disease-free survival were assessed from the day of operation to the latest outpatient examination. Postoperative morbidity and rehabilitation of feeding were also assessed. Six patients had major complications, four of whom had a second operation for necrosis of the flap. Actuarial five-year overall survival (OS) and disease-free survival were 54% and 47%. Twenty-four patients (65%) were operated on as their first treatment, and had 79% five-year overall survival and 61% 5-year disease-free survival. Twenty-six patients were eventually able to feed orally postoperatively. Although this retrospective study include a limited number of patients, the results support the validity of total glossectomy as a safe procedure for advanced cancer of the tongue. Pretreated patient were previously treated with surgery, radiotherapy or chemoradiotherapy with curative purposes. Nevertheless, the long period required for recovery of oral feeding indicates that total glossectomy should be reserved for highly motivated patients.


Oral Oncology | 2011

Compartmental tongue surgery: Long term oncologic results in the treatment of tongue cancer.

Luca Calabrese; Roberto Bruschini; Gioacchino Giugliano; Angelo Ostuni; Fausto Maffini; Maria Angela Massaro; Luigi Santoro; Valeria Navach; Lorenzo Preda; Daniela Alterio; Mohssen Ansarin; Fausto Chiesa

Compartmental tongue surgery (CTS) is a surgical technique that removes the compartments (anatomo-functional units) containing the primary tumor, eliminating the disease and potential muscular, vascular, glandular and lymphatic pathways of spread and recurrence. Compartment boundaries are defined as each hemi-tongue bounded by the lingual septum, the stylohyoid ligament and muscle, and the mylohyoid muscle. In this non-randomized retrospective study we evaluated the oncologic efficacy of CTS in patients with squamous cell carcinoma (SCCA) of the tongue treated from 1995 to 2008. We evaluated 193 patients with primary, previously untreated cT2-4a, cN0, cN+, M0 SCCA with no contraindication to anesthesia and able to give informed consent. Fifty patients treated between October 1995 and July 1999 received standard surgery (resection margin >1cm); 143 patients treated between July 1999 and January 2008 received CTS. Study endpoints were: 5-year local disease-free, locoregional disease-free and overall survival. After 5years, local disease control was achieved in 88.4% of CTS patients (16.8% improvement on standard surgery); locoregional disease control in 83.5% (24.4% improvement) and overall survival was 70.7% (27.3% improvement). The markedly improved outcomes in CTS patients, compared to those treated by standard surgery, suggest CTS as an important new approach in the surgical management of tongue cancer.


Head and Neck-journal for The Sciences and Specialties of The Head and Neck | 2015

Algorithm to predict postoperative complications in oropharyngeal and oral cavity carcinoma

Luigi Santoro; Marta Tagliabue; Maria Angela Massaro; Mohssen Ansarin; Luca Calabrese; Gioacchino Giugliano; Daniela Alterio; Maria Cossu Rocca; Enrica Grosso; Marek Planicka; Marco Benazzo; Fausto Chiesa

Preoperative data in patients with oral cavity/oropharyngeal cancer may predict postoperative complications that may modify therapeutic choices and improve patient care.


Current Opinion in Otolaryngology & Head and Neck Surgery | 2013

From wide excision to a compartmental approach in tongue tumors: what is going on?

Luca Calabrese; Marta Tagliabue; Fausto Maffini; Maria Angela Massaro; Luigi Santoro

Purpose of reviewSurgical approaches to tongue cancer have not changed substantially over the years. The literature proposes some indications for tumor excision even though type of intervention, resection margins, neck dissection, and ‘en bloc’ resection versus separate excision of tumor and lymph nodes do not seem to be standardized. The purpose of this review is to describe the evolution of surgical management of tongue carcinoma with particular attention to recent reports focusing on compartmental tongue surgery. Recent findingsThe current literature usually describes resection of tongue carcinoma within wide disease-free margins, ranging from 1.5 to 2 cm. In case of advanced-stage tumors, performing concomitant neck dissection is recommended; otherwise, a deferred neck dissection is indicated if depth of neoplastic infiltration exceeds 4 mm. In recent years, a new technical approach has been formulated based on anatomy of the tongue, thus, introducing the concept of an anatomy-based, function sparing, compartmental surgery. SummaryApplying such a proposal to clinical practice aims at standardizing a surgical procedure that otherwise might be arbitrary. Compartmental surgery improves overall survival, does not seem to worsen functional outcomes of the residual tongue, and allows comparison of case studies.


Acta Otorhinolaryngologica Italica | 2014

HPV in oropharyngeal cancer: the basics to know in clinical practice

S. Elrefaey; Maria Angela Massaro; Susanna Chiocca; Fausto Chiesa; Mohssen Ansarin


Acta Otorhinolaryngologica Italica | 2010

Laser surgery of early glottic cancer in elderly.

Mohssen Ansarin; Augusto Cattaneo; Luigi Santoro; Maria Angela Massaro; Stefano Zorzi; Enrica Grosso; Lorenzo Preda; Daniela Alterio


International Journal of Biological Markers | 2013

Detection of squamous cell carcinoma antigen with two systems in the follow-up of patients with cervical cancer

Maria Teresa Sandri; Michela Salvatici; Cristian Mauro; Davide Radice; Paola Lentati; Maria Angela Massaro; Sara Boveri; Laura Zorzino; F. Landoni


Journal of Evidence-Based Psychotherapies | 2017

Can group education improve adherence and enhance breast cancer rehabilitation after axillary dissection? A randomized clinical trial

Maria Claudia Simoncini; Luigi Santoro; Federica Baggi; Luiz Felipe Nevola Teixeira; Michele Sciotto Marotta; Fabio Sandrin; Emilio Bonacossa; Gabriella Lanni; Maria Angela Massaro; Mattia Intra; C. Berrocal

Collaboration


Dive into the Maria Angela Massaro's collaboration.

Top Co-Authors

Avatar

Mohssen Ansarin

European Institute of Oncology

View shared research outputs
Top Co-Authors

Avatar

Luigi Santoro

European Institute of Oncology

View shared research outputs
Top Co-Authors

Avatar

Fausto Chiesa

European Institute of Oncology

View shared research outputs
Top Co-Authors

Avatar

Luca Calabrese

European Institute of Oncology

View shared research outputs
Top Co-Authors

Avatar

Augusto Cattaneo

European Institute of Oncology

View shared research outputs
Top Co-Authors

Avatar

Gioacchino Giugliano

European Institute of Oncology

View shared research outputs
Top Co-Authors

Avatar

Marta Tagliabue

European Institute of Oncology

View shared research outputs
Top Co-Authors

Avatar

Daniela Alterio

European Institute of Oncology

View shared research outputs
Top Co-Authors

Avatar

Fausto Maffini

European Institute of Oncology

View shared research outputs
Top Co-Authors

Avatar

Lorenzo Preda

European Institute of Oncology

View shared research outputs
Researchain Logo
Decentralizing Knowledge